Understanding lung cancer treatment and outcomes through patient data collection

CRISP is a large research platform that gathers detailed information from patients with lung cancer—including non-small cell and small cell types—to understand what treatments doctors are using, what tests are being done, and how patients are doing. The study focuses especially on molecular testing (special genetic tests that can guide treatment choices) and collects information about patients' quality of life, anxiety, and depression throughout their treatment journey.

Doctors want to know how lung cancer is actually being treated in everyday practice and whether patients are receiving the best possible care. By collecting real-world information from many patients, researchers can identify gaps in treatment and develop better recommendations to improve care for people with lung cancer.